Sommario
Numerosi sono gli studi epidemiologici che hanno dimostrato l’esistenza di una correlazione tra disfunzione della sfera sessuale e patologie epatiche responsabili di danno cronico, tra cui si annoverano l’abuso alcolico, i virus epatitici (B, C e Delta) e le steatoepatiti non alcoliche. Scopo di questo articolo è illustrare i meccanismi fisiopatologici alla base della disfunzione sessuale nelle diverse epatopatie e le relative possibilità terapeutiche.
This is a preview of subscription content, log in via an institution to check access.
Bibliografia
Abuelhassan W (2012) Hepatitis C virus infection in 2012 and beyond. South Afr J Epidemiol Infect 27(3):93–97
Levitsky J, Mailliard ME (2004) Diagnosis and therapy of alcoholic liver disease. Semin Liver Dis 24(3):233–247
Marchesini G, Bugianesi E, Forlani G et al. (2003) Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37(4):917–923
Emanuele MA, Emanuele N (2001) Alcohol and the male reproductive system. Alcohol Res Health 25(4):282–287
Chung SD, Keller JJ, Liang YC, Lin HC (2012) Association between viral hepatitis and erectile dysfunction: a population-based case-control analysis. J Sex Med 9(5):1295–1302
Toda K, Miwa Y, Kuriyama S et al. (2005) Erectile dysfunction in patients with chronic liver disease: its relevance to protein malnutrition. J Gastroenterol 40:894–900
Esposito K, Giugliano D (2011) Obesity, the metabolic syndrome, and sexual dysfunction in men. Clin Pharmacol Ther 90(1):169–173
Durazzo M, Premoli A, Di Bisceglie C et al. (2010) Male sexual disturbances in liver diseases: what do we know? J Endocrinol Invest 33:501–505
Kraus MR, Schäfer A, Bentink T et al. (2005) Sexual dysfunction in males with chronic hepatitis C and antiviral therapy: interferon-induced functional androgen deficiency or depression? J Endocrinol 185:345–352
Dove LM, Rosen RC, Ramcharran D et al. (2009) Decline in male sexual desire, function, and satisfaction during and after antiviral therapy for chronic hepatitis C. Gastroenterology 137:873–884
Rosen RC, Cappelleri JC, Smith MD et al. (1999) Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11(6):319–326
Rosen RC, Riley A, Wagner G et al. (1997) The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49(6):822–830
Petrone L, Mannucci E, Corona G et al. (2003) Structured interview on erectile dysfunction (SIEDY): a new, multidimensional instrument for quantification of pathogenetic issues on erectile dysfunction. Int J Impot Res 15(3):210–220
Forgue ST, Phillips DL, Bedding AW et al. (2007) Effects of gender, age, diabetes mellitus and renal and hepatic impairment on tadalafil pharmacokinetics. Br J Clin Pharmacol 63:24–35
Deibert P, Schumacher YO, Ruecker G et al. (2006) Effect of vardenafil, an inhibitor of phosphodiesterase-5, on portal haemodynamics in normal and cirrhotic liver—results of a pilot study. Aliment Pharmacol Ther 23(1):121–128
Conflitto di interessi
Gli autori Chiara Manieri, Giovanna Motta, Cataldo Di Bisceglie, Erika Pistone e Marilena Durazzo dichiarano di non avere conflitti di interessi.
Consenso informato
L’articolo non contiene studi con sperimentazione umana effettuata dagli autori.
Studi sugli animali
L’articolo non contiene studi con sperimentazione animale effettuata dagli autori.
Author information
Authors and Affiliations
Corresponding author
Additional information
Proposta da Csilla Krausz.
Materiale elettronico supplementare
I link al materiale elettronico supplementare sono elencati qui sotto.
Rights and permissions
About this article
Cite this article
Manieri, C., Motta, G., Di Bisceglie, C. et al. Disfunzione erettile nel paziente epatopatico. L'Endocrinologo 15, 9–15 (2014). https://doi.org/10.1007/s40619-014-0003-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40619-014-0003-3